Skip to main content

Table 1 Patient characteristics in PSA progression tissue microarray

From: CD38 is methylated in prostate cancer and regulates extracellular NAD+

Characteristic

No recurrence (n = 499)

Recurrence (n = 499)

p value

Age at surgery

59.0 (6.0)

58.8 (6.3)

Matched

Race

  

Matched

 AA

39 (7.8%)

47 (9.4%)

 

 White

440 (88.2%)

426 (85.4%)

 

 Other

11 (2.2%)

19 (3.8%)

 

Gleason sum

  

Matched

 5

3 (0.6%)

3 (0.6%)

 

 6

69 (13.8%)

68 (13.6%)

 

 7

314 (62.9%)

305 (61.1%)

 

 8

113 (22.6%)

123 (24.6%)

 

S stage

  

Matched

 1

67 (13.4%)

66 (13.2%)

 

 2

260 (52.1%)

260 (52.1%)

 

 3

172 (34.5%)

173 (34.7%)

 

Pre-op PSA

11.0 (8.3)

12.3 (10.2)

0.026

Surgical margins +

110 (22.0%)

176 (35.3%)

< 0.001

  1. The PSA progression tissue microarray contains tissue cores from 499 men who developed biochemical recurrence and 499 controls who did not develop recurrence, matched based on age, race, Gleason sum, and pathologic stage. Patient characteristics were summarized using means/standard deviation and frequencies/percentages